Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Cano Health, Inc. CANO NYSE

NYSE • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
39/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$402.33
+17392.6%

Cano Health, Inc. (CANO) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $2.30. It has a SharesGrow Score of 39/100, indicating a weak investment profile with 1 out of 7 criteria passed.

Analyst consensus target is CANO = $402 (+17392.6% upside).

Financials: revenue is $2.7B, +97.9%/yr average growth. Net income is $428M (loss), growing at -156.9%/yr. Net profit margin is -15.6% (negative). Gross margin is 15.4% (-5.8 pp trend).

Balance sheet: total debt is $1.2B against $255M equity (Debt-to-Equity (D/E) ratio 4.7, leveraged). Current ratio is 1.63 (strong liquidity). Debt-to-assets is 62.2%. Total assets: $1.9B.

Analyst outlook: 0 / 10 analysts rate CANO as buy (0%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 58/100 (Partial), Past 0/100 (Fail), Health 33/100 (Fail), Moat 19/100 (Fail), Future 52/100 (Partial), Income 10/100 (Fail).

$402.33
▲ 17392.61% Upside
Average Price Target
Based on 10 Wall Street analysts offering 12-month price targets for Cano Health, Inc., the average price target is $402.33, with a high forecast of $832.00, and a low forecast of $125.00.
Highest Price Target
$832.00
Average Price Target
$402.33
Lowest Price Target
$125.00

CANO SharesGrow Score Overview

45/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 100/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 33/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 19/100
Gross margin is + market cap
FUTURE 52/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — CANO

✓
VALUE Pass
100/100
CANO trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Analyst consensus target is $402, implying +17378.3% from the current price $2. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
GROWTH Partial
58/100
CANO: +97.9%/yr revenue is, -156.9%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✗
HEALTH Fail
33/100
Balance sheet CANO: Debt-to-Equity (D/E) ratio 4.7 (leveraged), Current ratio is 1.63 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
19/100
CANO: Gross margin is 15.4% (-5.8 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 19/100. ≥ 70 = Pass.
View details →
~
FUTURE Partial
52/100
Analyst outlook: 0 / 10 analysts rate CANO as buy (0%). Analyst consensus target is $402 (+17378.3% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
10/100
CANO: Net profit margin is -15.6%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range1.739-190.0
Volume172.6K
Avg Volume (30D)385.28K
Market Cap$12.43M
Beta (1Y)0.05
Share Statistics
EPS (TTM)-195.46
Shares Outstanding$2.18M
IPO Date2020-07-02
Employees4,010
CEOMark Kent
Financial Highlights & Ratios
Revenue (TTM)$2.74B
Gross Profit$421.69M
EBITDA$970K
Net Income$-428.39M
Operating Income$-89.67M
Total Cash$27.33M
Total Debt$1.2B
Net Debt$1.17B
Total Assets$1.93B
Price / Earnings (P/E)-0
Price / Sales (P/S)0
Analyst Forecast
1Y Price Target$250.00
Target High$832.00
Target Low$125.00
Upside+10,769.6%
Rating ConsensusHold
Analysts Covering10
Buy 0% Hold 80% Sell 20%
Company Info
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS13781Y2028

Price Chart

Track all markets on TradingView
CANO
Cano Health, Inc. ↗  ·  NYSE
Healthcare • Medical - Care Facilities
1.74 52WK RANGE 190.00

People Also View

THC
THC
Tenet Healthcare Corporation
$196.60
+1.87%
 UHS
UHS
Universal Health Services, Inc.
$181.95
-0.68%
 ENSG
ENSG
The Ensign Group, Inc.
$198.45
-0.92%
 BKD
BKD
Brookdale Senior Living Inc.
$13.92
+2.35%
 LFST
LFST
LifeStance Health Group, Inc.
$6.51
+0.77%
 ACHC
ACHC
Acadia Healthcare Company, Inc.
$26.56
+0.04%
 SEM
SEM
Select Medical Holdings Corporation
$16.38
-0.06%
 AMEH
AMEH
Apollo Medical Holdings, Inc.
$40.82
-2.11%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message